Background
==========

Thromboses at unusual sites are characteristic of polycythaemia. They include occlusion of the splenic, portal, hepatic and mesenteric veins. There were neither reports of renal vein thrombosis (RVT) due to polycythaemia in adults nor had the aetiology of RVT in adults \[[@bib1]\] included polycythaemia as one of the causes.

Case report
===========

A 28-year-old gentleman, non-smoker, teetotaller, non-diabetic and non-hypertensive, presented with the complaints of dysuria, haematuria of one episode and swelling of the left lower limb over 5 days. There was no history of fever, loin pain, oliguria, headache, weakness, pruritus, dizziness, visual disturbances, joint pains, chest pain or breathlessness. Systemic examination was unremarkable. The investigations were in the [Table 1](#tbl1){ref-type="table"}.

###### 

Investigations[a](#tblfn1){ref-type="table-fn"}

  Investigations (results in SI units)                                       On the first visit                                                                                                                                         After 1 month
  -------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------
  Haemoglobin (g/L)                                                          125--127                                                                                                                                                   156
  Haematocrit (%)                                                            38--40                                                                                                                                                     47
  Leucocycte count (per mm^3^)                                               10 100--13 000                                                                                                                                             13 500
  Platelet count (lakhs/mm^3^)                                               5.31--5.5                                                                                                                                                  4.8
  Peripheral smear                                                           not done                                                                                                                                                   Normocytic normochromic RBCs
  Serum creatinine (μmol/L)                                                  88.4                                                                                                                                                       79.6
  Serum proteins (g/L)                                                       70                                                                                                                                                         80
  Serum albumin (g/L)                                                        32                                                                                                                                                         46
  24-h urine protein (mg/day)                                                525                                                                                                                                                        138
  Urine examination                                                          pH: 6.0; specific gravity: 1015; albumin: 1+; glucose: nil; ketones: absent; RBCS: 6--10/h.p.f.; WBC: 6--8/h.p.f.                                          pH: 6.0; specific gravity: 1020; albumin: 1+ glucose: nil; ketones: absent; RBCS: 4--6/h.p.f.; WBC: 2/h.p.f.
  Serum homocysteine \[reference range: \<15 μmol/L)\]                       19                                                                                                                                                         not done
  Thyroid-stimulating hormone (reference range: 1.3--3.0 nmol/L)             2.6                                                                                                                                                        not done
  Lactate dehydrogenase (reference range: 200--400 IU/L)                     558                                                                                                                                                        not done
  ANA                                                                        Negative                                                                                                                                                   not done
  Anti-dsDNA                                                                 Negative                                                                                                                                                   not done
  Anticardiolipin antibodies, IgG, IgA, IgM                                  Negative                                                                                                                                                   not done
  HbsAg                                                                      Negative                                                                                                                                                   not done
  Anti-HCV antibodies                                                        Negative                                                                                                                                                   not done
  HIV                                                                        Non-reactive                                                                                                                                               not done
  Doppler of venous system of lower limbs                                    Sub-acute thrombosis, right and left common iliac, external iliac, common femoral, superficial femoral, poplitaeal, anterior and posterior tibial veins.   not done
  Partial recanalization of inferior vena cava, both renal veins at hilum.                                                                                                                                                              
  Bone marrow biopsy                                                         not done                                                                                                                                                   Trilineage hyperplasia ([Figure 1](#fig1){ref-type="fig"})
  Serum erythropoietin (reference range: 3.7 to 31.5 mU/mL)                  not done                                                                                                                                                   6.30
  JAK 2 V617F mutation                                                       not done                                                                                                                                                   Detected in blood by PCR
  ABG                                                                        not done                                                                                                                                                   pH: 7.466; pCO~2~: 43.5 mmHg; PO~2~: 96.5 mmHg; HCO3: 30.9 mmol/L

PCR, polymerase chain reaction; ANA, Anti nuclear antibody; HCV, Hepatitis C virus; ABG, Arterial blood gas analysis; dsDNA, double stranded DNA.
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Discussion
==========

Often patients with splanchnic vein thrombosis, as in this patient, have normal haemoglobin and haematocrit levels. This phenomenon is regarded as 'inapparent polycythaemia vera' (IPV) \[[@bib2]\]. The concept of IPV is observed in two circumstances. The first one is in patients where increased plasma mass masks an increased red cell mass. This is observed in patients of portal hypertension secondary to suprahepatic or portal vein thrombosis \[[@bib3], [@bib4]\]. In the series of Valla *et al* \[[@bib3]\], among the four patients with portal vein thrombosis and increased plasma volume, the maximum haemoglobin observed was 140 g/L. Gastrointestinal bleeding and/or an increase in portal vein hypertension often explain the apparent normal result of the blood count.

The second one is in the event of a standard iron deficiency during polycythaemia vera (PV) and is partly explained by the high frequency of gastric ulcers and gastritis estimated at 20--30% \[[@bib5]\]. Resulting iron deficiency can be accompanied by hypochromia and microcytosis and occasionally a substantial decrease in haemoglobin levels. In this situation, PV is not always easy to diagnose, especially in the absence of splenomegaly and leucocytosis. Thrombocytosis may be present but secondary to iron deficiency. Iron supplementation and treatment of the local cause of bleeding enable the diagnosis to be reestablished, for the increase in haematocrit and haemoglobin levels is abnormal and rapid. \[[@bib5]\]

The real frequency of IPV is not yet established; but in one series, its frequency was 18 of 103 patients (17%) \[[@bib5]\]. The red cell mass measurement to diagnose IPV is required in patients of isolated and unexplained thrombocytosis, hyperleucocytosis, splenomegaly or splanchanic vein thrombosis. \[[@bib5]\] But with the advent of the molecular tests for the JAK2V617F mutation, the diagnosis of IPV has been dramatically simplified \[[@bib6]\]. Because JAK2V617F is myeloid neoplasm specific and not found in other causes of polycythaemia, it has lent itself to being a sensitive diagnostic marker for PV. However, in the context of myeloid neoplasms, JAK2V617F is not specific for PV and is found in ∼50% of patients with essential thrombocythemia (ET), primary myelofibrosis (PMF) or 'refractory anaemia with ringed sideroblasts associated with marked thrombocytosis' and at a lesser frequency in other myeloid neoplasms but not in lymphoid tumours. Therefore, mutation screening for JAK2V617F cannot be used to distinguish one myeloproliferative neoplasm from another, but it does complement histology in the diagnosis of both ET and PMF by excluding the possibility of reactive thrombocytosis or myelofibrosis \[[@bib6]\].
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